文献速递垂体与肾上腺疾病

库欣病与静默型促肾上腺皮质激素腺瘤的遗传改变差异

Distinct genetic alterations drive Cushing disease vs silent corticotroph adenomas.
PubMed 文献 · J Clin Endocrinol Metab · 2026-01-01

本研究对34例患者的38个促肾上腺皮质激素腺瘤行全外显子测序、拷贝数变异分析与mRNA测序,整合临床、影像与病理资料。结果显示USP8/USP48突变型库欣病为低拷贝数变异、低风险亚型,而TP53/ATRX/DAXX突变肿瘤拷贝数变异高、临床侵袭性强。拷贝数与突变谱或可辅助术后风险分层。

要点

  • USP8/USP48突变见于48%的库欣病肿瘤,与低拷贝数变异、低侵袭及术后良好缓解相关。
  • 13例静默型腺瘤中5例携带TP53/ATRX/DAXX突变,均有拷贝数变异显著升高和侵袭性临床特征。
  • 高拷贝数变异与影像侵袭、持续病变及复发或进展等侵袭性指标显著相关。

核心结论

  • 促肾上腺皮质激素腺瘤可分为不同分子亚型:USP8/USP48突变型库欣病为低拷贝数变异、低风险组,TP53/ATRX/DAXX突变肿瘤拷贝数变异高且临床行为侵袭。
  • 拷贝数与突变谱分析可能有助于术后风险分层。

研究设计与样本

  • 38个肿瘤来自34例患者,接受全外显子测序、拷贝数变异分析和mRNA测序,并与临床、影像和病理数据整合。

主要发现

  • 21个库欣病肿瘤中10个(48%)存在USP8/USP48突变,与低拷贝数变异水平、微小侵袭和术后良好缓解相关。
  • 13个静默型促肾上腺皮质激素腺瘤中5个携带TP53/ATRX/DAXX突变,全部拷贝数变异显著升高并具侵袭性临床特征。
  • 转录组分析发现ATRX-FAM138A mRNA融合,导致一个侵袭性肿瘤中ATRX表达缺失。
  • 无监督转录组分析界定4个聚类:USP8/USP48突变型库欣病聚为低拷贝数变异、低复发率组;第4类为高拷贝数变异肿瘤,富集TP53/ATRX/DAXX改变,影像侵袭、持续病变及复发或进展率最高。
  • 整个队列中,较高拷贝数变异与侵袭性参数显著相关。

临床怎么用

  • 对促肾上腺皮质激素腺瘤可考虑拷贝数变异与USP8/USP48、TP53/ATRX/DAXX突变谱检测,以辅助术后风险分层。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Corticotroph adenomas (CA) include functioning tumors causing Cushing disease (CD) and silent corticotroph adenomas (SCA), which differ markedly in size, clinical presentation, and aggressiveness. The molecular basis for these differences remains incompletely understood. OBJECTIVE: To characterize genomic and transcriptomic alterations underlying the divergent clinical behavior of CD and SCA. METHODS: Thirty-eight tumors from 34 patients underwent whole-exome sequencing, copy-number variation (CNV) analysis, and mRNA sequencing. Molecular findings were integrated with clinical, radiological, and pathological data. RESULTS: USP8/USP48 mutations were present in 10 of 21 CD tumors (48%) and were associated with low CNV levels, minimal invasion, and favorable post-operative remission. In contrast, five of 13 SCAs harbored TP53/ATRX/DAXX mutations, all had markedly elevated CNV, and aggressive clinical features. Transcriptomic analysis identified an ATRX-FAM138A mRNA fusion, resulting in loss of ATRX expression in an aggressive tumor. Unsupervised transcriptome analyses defined four clusters. All USP8/USP48-mutant CD clustered together had low CNV and low recurrence rates. Cluster 2 consisted of a mixture of CD and SCA, with intermediate CNV and nonaggressive behavior. Cluster 3 included USP8-wildtype CD with heterogeneous yet generally nonaggressive courses. Cluster 4 represented high-CNV tumors enriched for TP53/ATRX/DAXX alterations, with the highest rates of radiological invasion, persistent disease, and recurrence or progression. Across the cohort, higher CNV was significantly associated with parameters of aggressiveness. CONCLUSION: CA comprise distinct molecular subtypes. USP8/USP48-mutant CD represents a low-CNV, low-risk group, whereas tumors harboring TP53/ATRX/DAXX mutations exhibit high CNV and aggressive clinical behavior. CNV and mutation profiling may assist in postoperative risk stratification.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Paes T, Zhang Q, Borges CO, et al. Distinct genetic alterations drive Cushing disease vs silent corticotroph adenomas. J Clin Endocrinol Metab. 2026. PMID: 42273717. doi:10.1210/clinem/dgag229

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。